TRELLIS BIOSCIENCE RAISES $9 MILLION TO ADVANCE CLINICAL DEVELOPMENT OF CALPURBATUG (TRL1068)

General Arizona Archived • July 16, 2026 •

Funding will support continued development of Calpurbatug (TRL1068), a novel therapy being evaluated for prosthetic joint infections (PJI)

Source: https://tucson.com/search/?f=rss&t=article&l=50&s=start_time&sd=desc - Read Original

"Adventure is where you chose to go."

FB X ✉️

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!